Medicare Plans Coverage for All Treatments of Actinic Keratoses

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 10 No 10
Volume 10
Issue 10

WASHINGTON-Medicare will soon institute a policy to cover all its beneficiaries for treatments to remove actinic keratoses, sun-induced precancerous skin lesions confined to the epidermis. The decision establishes the first national coverage policy for the disorder without restrictions based on lesion or patient characteristics.

WASHINGTON—Medicare will soon institute a policy to cover all its beneficiaries for treatments to remove actinic keratoses, sun-induced precancerous skin lesions confined to the epidermis. The decision establishes the first national coverage policy for the disorder without restrictions based on lesion or patient characteristics.

Previously, some Medicare contractors had restricted coverage to specific lesion types, such as those located on specific parts of the body, or to certain patients, such as those with a history of skin cancer.

Recent Videos
According to Jorge Nieva, MD, there are a multitude of things that can be explored to enhance the treatment landscape for lung cancer.
5 experts are featured in this series
2 experts are featured in this series.
5 experts are featured in this series
2 experts are featured in this series.
Taletrectinib showed improved efficacy in patients with ROS1-positive non–small cell lung cancer who were treatment-naïve.
“It’s a drug that I’m very comfortable with, and it is a drug I’ll likely use primarily in the first-line setting,” stated Jorge Nieva, MD, on taletrectinib in non–small cell lung cancer.
4 experts in this video
4 experts in this video
Those being treated for peritoneal carcinomatosis may not have to experience the complication rates or prolonged recovery associated with surgical options.
Related Content